Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
S-1 with Radiotherapy in Esophageal Squamous Cell Carcinoma
NCT01831531Phase 2Completed
- Sponsor
- Fudan University
- Start
- Mar 2013
- Primary completion
- Oct 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tegafur in Esophageal Squamous Cell Carcinoma (ESCC), sponsored by Fudan University. Started Mar 2013; status: completed.
02
Drugs
tegafur
03
Conditions
Esophageal Squamous Cell Carcinoma (ESCC)
Beyond the preview
Go deeper on NCT01831531.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01831531.